Diagnosis and treatment strategies of inflammatory myofibroblastic tumor of the gastrointes-tinal tract
10.3760/cma.j.cn115610-20220612-00323
- VernacularTitle:胃肠道炎性肌纤维母细胞瘤的诊断与治疗策略
- Author:
Taiyuan LI
1
;
Gengmei GAO
Author Information
1. 南昌大学第一附属医院普通外科，南昌 330006
- Keywords:
Stomach neoplasms;
Inflammatory myofibroblastic tumor;
Diagnosis;
Treat-ment;
Prognosis;
Surgery
- From:
Chinese Journal of Digestive Surgery
2022;21(8):1038-1043
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory myofibroblastic tumor (IMT) of gastrointestinal tract is a rare and low malignant mesenchymal tumor, which is composed of differentiated myofibroblastoid spindle cells and often accompanied by numerous inflammatory cells such as plasma cells, lymphocytes, and eosinophils. Surgical resection is the preferred treatment for IMT of gastrointestinal tract, and patients can achieve a good prognosis after surgery. In recent years, with the progress of imaging examination and pathological diagnosis technology, the detection rate of IMT of gastrointes-tinal tract has been greatly improved, but its pathogenesis and mechanism have not been completely investigated, requiring further research results to confirm. At the same time, due to the lack of standardized strategies for diagnosis and treatment of IMT of gastrointestinal tract, it was inevitable to miss diagnosis or treatment in clinical diagnosis and treatment. By reviewing relevant literatures and combined with the team's practical experience, the authors summarize the research progress of the diagnosis and treatment of IMT of gastrointestinal tract from the aspects of pathogenesis, clinical diagnosis and treatment strategies of IMT, aiming to provide references for the clinical treatment of surgeons.
